# Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection

> **NCT03655847** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 42 (estimated)

## Conditions studied

- Delirium
- Postoperative Complications
- Pathologic Processes
- Neurocognitive Disorders
- Mental Disorders
- Dexmedetomidine
- Hypnotics and Sedatives
- Physiological Effects of Drugs
- Analgesics
- Molecular Mechanisms of Pharmacological Action

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT03655847
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-23
- **Primary completion:** 2020-03-23
- **Final completion:** 2020-04-23
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03655847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03655847, "Acceptable Hemodynamic Changes in Dexmedetomidine for Single Intravenous Bolus Injection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03655847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*